A comprehensive view of Johnson & Johnson Services Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GlobalData: J&J discontinuing talc-based baby powder and shifting to cornstarch-based baby powder is step in right direction to restore trust among risk-averse consumers; survey finds 79% global consumers prefer ‘natural’ and 'free from' formulations
Published: August 16, 2022 by GlobalData Plc
J&J to destroy about 135 million doses of its COVID-19 vaccine made at the Emergent BioSolutions plant in Baltimore, Maryland, between August 2021 and February due to quality problems; J&J destroyed over 400 million doses of the vaccine earlier
Published: August 15, 2022 by Associated Press
J&J to halt sales of talc powder worldwide in 2023 and replace it with cornstarch-based version; the talc powder was the subject of numerous health-related lawsuits, with J&J paying US$7.4B in talk-related litigation expenses from 2020-2021
Published: August 15, 2022 by FiercePharma
Johnson & Johnson Consumer Health to transition to all cornstarch-based baby powder products, will discontinue talc-based Johnson's Baby Powder globally in 2023; company maintains its talc-based baby powder does not contain asbestos, does not cause cancer
Published: August 12, 2022 by Johnson & Johnson Services Inc.
J&J files arbitration request alleging breach of contract by contract manufacturer Emergent Biosolutions in COVID-19 vaccination production dispute; Emergent claims J&J owes them US$420 for allegedly breaching their contract
Published: August 03, 2022 by FiercePharma

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count